U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906640) titled 'Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)' on Feb. 21.
Brief Summary: IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Chronic Kidney Disease(CKD)
Type 2 DM
Type 2 Diabetes Mellitus (T2DM)
Intervention:
OTHER: (IRIS-CKD Management Program): Education
Patients randomized to the education arm will receive targeted education materials regarding their severit...